MaSTherCell Competitors and Similar CompaniesClear all

MaSTherCell's competitors and similar companies include Eurogentec, ProKidney-US, Bioinova and CRISPR Therapeutics.
MaSTherCell
MaSTherCell
MaSTherCell is a contract development and manufacturing company dedicated to the industrialization and production of cell and gene therapies for third parties.
Eurogentec
Eurogentec
Eurogentec is a company active in the life science research, diagnostic, and pharmaceutical markets.
ProKidney-US
ProKidney-US
ProKidney-US (formerly known as Twin City Bio) is a contract development and manufacturing organization for biopharmaceuticals.
Bioinova
Bioinova
Bioinova is a biotechnology company that specializes in stem cell-based therapies.
CRISPR Therapeutics
CRISPR Therapeutics
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Founding Date
Founding Date
2011
Founding Date
1985
Founding Date
N/A
Founding Date
2008
Founding Date
2013
Type
Type
Subsidiary
Type
Subsidiary
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
HQ
Locations
Seraing, BE HQ
Seraing, BE
Fremont, US
Locations
Winston-Salem, US HQ
Locations
CZ HQ
Locations
Zug, CH HQ
Greater London, GB
Cambridge, US
San Francisco, US
Employees
Employees
264% decrease
Employees
393
Employees
6
Employees
11
Employees
393
For sources of this data, please see the company profile

View Company Profiles

Eurogentec
HQ
Seraing, BE

Eurogentec is a company active in the life science research, diagnostic, and pharmaceutical markets.

View company
ProKidney-US
HQ
Winston-Salem, US
Employees
6

ProKidney-US (formerly known as Twin City Bio) is a contract development and manufacturing organization for biopharmaceuticals.

View company
Bioinova
HQ
CZ
Employees
11

Bioinova is a biotechnology company that specializes in stem cell-based therapies.

View company
CRISPR Therapeutics
HQ
Zug, CH
Employees
393

CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.

View company